Topic

Orphan Biovitrum (Sobi)

1 article

Sweden’s Sobi to Buy US Biotech Arthrosi for up to $1.5 Billion to Boost Gout Pipeline
News 16 Dec 2025

Sweden’s Sobi to Buy US Biotech Arthrosi for up to $1.5 Billion to Boost Gout Pipeline

Swedish Orphan Biovitrum (Sobi) has agreed to acquire US-based biotechnology company Arthrosi Therapeutics in a deal worth up to $1.5…